<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-F61XRGZB</identifier><date>2022</date><creator>Bezeljak, Urban</creator><relation>documents/doc/F/URN_NBN_SI_doc-F61XRGZB_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-F61XRGZB_001.txt</relation><format format_type="issue">1</format><format format_type="volume">56</format><format format_type="type">article</format><format format_type="extent">str. 1-13</format><identifier identifier_type="DOI">10.2478/raon-2022-0002</identifier><identifier identifier_type="ISSN">1581-3207</identifier><identifier identifier_type="COBISSID_HOST">97371651</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-F61XRGZB</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">bioprocesna platforma</subject><subject language_type_id="slv">genska terapija</subject><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">onkolitični virus</subject><subject language_type_id="slv">virusni vektor</subject><title>Cancer gene therapy goes viral</title><title>viral vector platforms come of age</title></Record>